Dave Mu
About Dave Mu
Dave Mu is the Associate Director, IT Business Partner for Clinical Trial Management at Bristol Myers Squibb, with over a decade of experience in the life sciences and clinical trial management industry.
Current Position at Bristol Myers Squibb
Dave Mu currently serves as the Associate Director, IT Business Partner - Clinical Trial Management at Bristol Myers Squibb. Based in Princeton, New Jersey, Dave has been in this leadership role since August 2021. In this position, he oversees IT strategies and solutions that support clinical trial management, leveraging his extensive experience in the life sciences sector.
Previous Roles at Accenture
Prior to his current role, Dave Mu worked at Accenture from 2016 to 2021, contributing to life sciences technology consulting. Initially joining as a Consultant, he was promoted to Manager within a year. During his tenure in the Greater Philadelphia Area, he specialized in technology solutions for the life sciences industry, enhancing processes and systems for various clients.
Career at Almac Clinical Technologies
Dave Mu started his career in clinical trial management technology at Almac Clinical Technologies in 2009. Over seven years, he transitioned from a QA Analyst role to a Design Manager. His roles at Almac included QA Analyst, Senior QA Analyst, QA Analyst IV, and finally Design Manager in the San Francisco Bay Area. His progression within the company highlights his expertise in quality assurance and design in clinical technologies.
Educational Background
Dave Mu holds a Bachelor of Science in Engineering (BSE) in Chemical and Biomolecular Engineering from the University of Pennsylvania. His academic background in engineering provided a strong foundation for his career in the life sciences and clinical trial management industries.
Industry Expertise
With over a decade of experience in the life sciences and clinical trial management industry, Dave Mu has accumulated extensive knowledge and expertise. His career journey from Almac Clinical Technologies to senior roles in IT and management consulting at Accenture, and finally to his current leadership role at Bristol Myers Squibb, underscores his deep understanding of clinical trial technologies and IT solutions.